BioSpace News Archive

Nucleix Announces Publication of Non-Invasive Bladder Cancer Recurrence Detection Study Showing Best-in-Class Performance

Results of the European multi-center study of Bladder EpiCheck™ urine test, supporting reduction of invasive procedures, were published in the European Urology Oncology journal

July 24, 2018
·
4 min read
Business

Pall Corporation and BioSciencesCorp Launch Strategic Partnership to Support Industry Drive Towards Integrated End-to-End Bioprocessing

Together they will deliver cost-effective manufacturing strategies, and efficient upstream and downstream process equipment and facility design solutions for manufacturers.

July 24, 2018
·
3 min read
Business

Delphi Behavioral Health Group Announces Opening of New Perspectives

Leading Health Group Adds New South Florida Outpatient Treatment Facility

July 24, 2018
·
3 min read
Business

Soligenix Announces Appointment of Mark Pearson to its Board of Directors

Soligenix intends to leverage Mr. Pearson’s extensive business and investing experience

July 24, 2018
·
6 min read
Drug Development

Janssen Presents Switch Data for New HIV-1 Treatment SYMTUZA™ (D/C/F/TAF) and Second Study Supporting its Use in a Rapid Initiation Scenario

Phase 3 EMERALD and DIAMOND studies at AIDS 2018 reinforce the safety and efficacy of the first darunavir-based HIV-1 single-tablet regimen

July 24, 2018
·
15 min read
Biotech Bay

AHRA and Canon Medical Systems Add Two Additional Grants to Putting Patients First Program as It Celebrates 11 Years of Improving Patient Care

Program Funds Eight Grants, Including New Categories for Oncology and Cybersecurity

July 24, 2018
·
4 min read
BioMidwest

Lilly to Separate Elanco Animal Health with Initial Public Offering

Company has completed its strategic review of Elanco Animal Health, and will file a registration statement in the coming weeks with the U.S. Securities and Exchange Commission

July 24, 2018
·
3 min read
Business

Lilly Delivers Strong Second-Quarter 2018 Results, Revises EPS Guidance

Second-quarter 2018 revenue increased 9 percent, driven primarily by the increased demand for new pharmaceutical products, while operating expenses declined.

July 24, 2018
·
56 min read
Business

MAXIMUS Awarded $11.7 Million Enrollment Broker Contract for Wisconsin Department of Health Services

The contract was awarded on November 1, 2017.

July 24, 2018
·
2 min read
Business

Sage Therapeutics to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018

Sage Therapeutics today announced that the company will host a conference call and live webcast on Tuesday, August 7, 2018 at 8:00 A.M. ET to report its second quarter 2018 financial results.

July 24, 2018
·
1 min read